SCHEMBL1369749

SCHEMBL1369749

COc1cccc2oc(=O)c(C(=O)c3cc4c(OC)cccc4oc3=O)cc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.58
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
CA9 Q16790 2/20 0.58
CNR2 P34972 1/20 0.57
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
HTT P42858 1/20 0.55
CYP2A6 P11509 1/20 0.54
CNR1 P21554 1/20 0.53
GPR55 Q9Y2T6 1/20 0.53
MAOB P27338 2/20 0.52
CA3 P07451 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CA5A P35218 1/20 0.49
CA7 P43166 1/20 0.49
CA14 Q9ULX7 1/20 0.49
CA5B Q9Y2D0 1/20 0.49
ALDH1A1 P00352 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1366644 0.91 CA12 (0.58) CA12CA1CA2CA9CNR2
SCHEMBL11337793 0.90 CA12 (0.62) CA12CA1CA2CA9CNR2
SCHEMBL1368982 0.87 CNR2 (0.56) CA12CA1CA2CA9CNR2
SCHEMBL9923789 0.80 CA12 (0.62) CA12CA1CA2CA9CNR2
SCHEMBL556704 0.79 ALDH1A1 (0.55) CA12CA1CA2CA9CNR2
SCHEMBL29436270 0.79 ALDH1A1 (0.55) CA12CA1CA2CA9CNR2
SCHEMBL11098426 0.78 MEN1 (0.77) CA12CA1CA9MEN1KMT2A
SCHEMBL4567092 0.78 NPC1 (0.59) CA12CA1CA9MEN1KMT2A
SCHEMBL11622415 0.78 CNR2 (0.71) CA12CA1CA2CA9CNR2
SCHEMBL51844 0.76 MEN1 (0.50) CNR2MEN1KMT2AHTTCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS CA12 4005/4885CA1 4493/4885CA2 3563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.